We are into the second year of the COVID-19 pandemic which is caused by an RNA virus, belonging to the severe acute respiratory syndrome (SARS) family. Though the mainstay of COVID management continues to be mainly symptomatic, many new management options are coming up. Due to ethical reasons, pregnant and lactating women are never included in the clinical trials used to test drug safety and efficacy, but COVID-19 is here to stay and we should begin to analyse the effects of the various proposed drugs in its management in pregnant population.
Background: Pelvic organ prolapse complicating pregnancy is an extremely rare entity. Obstetricians must be familiar with this condition as early recognition and follow up can help to avoid possible fetomaternal risks. Isolated cystocele in pregnancy has not been reported in literature till now. Case reports available mention concomitant uterovaginal prolapse along with cystocele. Case Report: We present a patient with isolated cystocele during pregnancy. She presented to us at 28 weeks gestation with cystocele protruding out of the introitus with complaints of preterm labour pains. She was managed conservatively, but had preterm vaginal delivery at 30 weeks gestation. Both mother and baby are healthy following delivery.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.